Stock BLND BLEND LABS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Blend Labs, Inc.

Equities

BLND

US09352U1088

Real-time Estimate Cboe BZX
Other stock markets
 01:34:38 2024-06-06 pm EDT 		5-day change 1st Jan Change
2.735 USD -2.32% Intraday chart for Blend Labs, Inc. -4.88% +7.06%
May. 15 Blend Labs Insider Sold Shares Worth $1,992,950, According to a Recent SEC Filing MT
May. 08 (BLND) BLEND Sees Q2 Revenue Range $37.5M - $41.5M MT

Evolution of the average Target Price on Blend Labs, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a434daa4ff830d076d3.ktzCHr5Y5Q2n-QgiAvH26AVc5Exjwv72SBCJzeOe2Gw.qquheMYrvU7vrn1HZJq4vWo5sgkai7yhP1S_parkjSvot6RV5wjVRt3Jfw~d44aeb36034665c296733f0ab57b42cd

Analyst Recommendations on Blend Labs, Inc.

Blend Labs Insider Sold Shares Worth $1,992,950, According to a Recent SEC Filing MT
Canaccord Genuity Adjusts Blend Labs Price Target to $3 From $2, Maintains Hold Rating MT
Keefe, Bruyette & Woods Adjusts Price Target on Blend Labs to $2.65 From $1.85, Maintains Market Perform Rating MT
Goldman Sachs Adjusts Price Target on Blend Labs to $3.10 From $1.60, Maintains Buy Rating MT
UBS Adjusts Blend Labs Price Target to $3 From $1, Maintains Neutral Rating MT
Wells Fargo Upgrades Blend Labs to Overweight From Equalweight, Raises PT to $3.50 From $1.50 MT
Goldman Sachs Adjusts Price Target on Blend Labs to $1.60 From $1.40, Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on Blend Labs to $1.40 From $1.30, Maintains Buy Rating MT
Wells Fargo Adjusts Price Target on Blend Labs to $1.50 From $1, Maintains Equal-Weight Rating MT
Goldman Sachs Adjusts Price Target on Blend Labs to $1.30 From $1.50, Maintains Buy Rating MT
UBS Adjusts Blend Labs Price Target to $1 From $2, Maintains Neutral Rating MT
Goldman Sachs Adjusts Price Target on Blend Labs to $1.50 From $2.50, Maintains Buy Rating MT
Piper Sandler Adjusts Price Target on Blend Labs to $1.30 From $2.40, Keeps Neutral Rating MT
Wells Fargo Adjusts Price Target on Blend Labs to $1.50 From $2, Maintains Equalweight Rating MT
Canaccord Genuity Adjusts Price Target on Blend Labs to $2 From $3, Maintains Hold Rating MT
Keefe, Bruyette & Woods Adjusts Price Target on Blend Labs to $1.40 From $1.30, Maintains Market Perform Rating MT
UBS Adjusts Blend Labs Price Target to $2 From $3, Maintains Neutral Rating MT
Wells Fargo Adjusts Price Target on Blend Labs to $2 From $2.50, Maintains Equal-Weight Rating MT
Compass Point Adjusts Blend Labs Price Target to $3 From $4.20, Maintains Neutral Rating MT
Canaccord Genuity Adjusts Price Target on Blend Labs to $3 From $4, Maintains Hold Rating MT
Keefe Bruyette & Woods Upgrades Blend Labs to Market Perform From Underperform, Price Target is $2.25 MT
Wells Fargo Adjusts Price Target on Blend Labs to $2.50 From $3, Maintains Equal-Weight Rating MT
Goldman Sachs Adjusts Price Target on Blend Labs to $3.25 From $5.25, Keeps Buy Rating MT
Canaccord Genuity Adjusts Blend Labs' Price Target to $4 From $5, Reiterates Hold Rating MT
Keefe, Bruyette & Woods Downgrades Blend Labs to Underperform From Market Perform, Lowers Price Target to $2.75 From $4 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.8 USD
Average target price
3.1 USD
Spread / Average Target
+10.71%
High Price Target
3.5 USD
Spread / Highest target
+25.00%
Low Price Target
3 USD
Spread / Lowest Target
+7.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Blend Labs, Inc.

Canaccord Genuity
Keefe, Bruyette & Woods
Goldman Sachs
UBS
Wells Fargo Securities
Piper Sandler
Compass Point
KeyBanc Capital Markets
William Blair & Co.
Truist Securities

Ratings for Blend Labs, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BLND Stock
  4. Consensus Blend Labs, Inc.